These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8626425)

  • 1. Bcl-x(S) anatagonizes the protective effects of Bcl-x(L).
    Minn AJ; Boise LH; Thompson CB
    J Biol Chem; 1996 Mar; 271(11):6306-12. PubMed ID: 8626425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BH3 domain of Bcl-x(S) is required for inhibition of the antiapoptotic function of Bcl-x(L).
    Chang BS; Kelekar A; Harris MH; Harlan JE; Fesik SW; Thompson CB
    Mol Cell Biol; 1999 Oct; 19(10):6673-81. PubMed ID: 10490606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bax can antagonize Bcl-XL during etoposide and cisplatin-induced cell death independently of its heterodimerization with Bcl-XL.
    Simonian PL; Grillot DA; Merino R; Nuñez G
    J Biol Chem; 1996 Sep; 271(37):22764-72. PubMed ID: 8798452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2.
    Zha H; Aimé-Sempé C; Sato T; Reed JC
    J Biol Chem; 1996 Mar; 271(13):7440-4. PubMed ID: 8631771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. harakiri, a novel regulator of cell death, encodes a protein that activates apoptosis and interacts selectively with survival-promoting proteins Bcl-2 and Bcl-X(L).
    Inohara N; Ding L; Chen S; Núñez G
    EMBO J; 1997 Apr; 16(7):1686-94. PubMed ID: 9130713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regions outside of the Bcl-2 homology domains, BH1 and BH2 protect a dopaminergic neuronal cell line from staurosporine-induced cell death.
    Oh YJ; Uhland-Smith A; Kim JE; O'Malley KL
    Brain Res Mol Brain Res; 1997 Nov; 51(1-2):133-42. PubMed ID: 9427515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-xL regulates apoptosis by heterodimerization-dependent and -independent mechanisms.
    Minn AJ; Kettlun CS; Liang H; Kelekar A; Vander Heiden MG; Chang BS; Fesik SW; Fill M; Thompson CB
    EMBO J; 1999 Feb; 18(3):632-43. PubMed ID: 9927423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peptides derived from BH3 domains of Bcl-2 family members: a comparative analysis of inhibition of Bcl-2, Bcl-x(L) and Bax oligomerization, induction of cytochrome c release, and activation of cell death.
    Shangary S; Johnson DE
    Biochemistry; 2002 Jul; 41(30):9485-95. PubMed ID: 12135371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bax-independent inhibition of apoptosis by Bcl-XL.
    Cheng EH; Levine B; Boise LH; Thompson CB; Hardwick JM
    Nature; 1996 Feb; 379(6565):554-6. PubMed ID: 8596636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl2-L-10, a novel anti-apoptotic member of the Bcl-2 family, blocks apoptosis in the mitochondria death pathway but not in the death receptor pathway.
    Zhang H; Holzgreve W; De Geyter C
    Hum Mol Genet; 2001 Oct; 10(21):2329-39. PubMed ID: 11689480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax.
    Yin XM; Oltvai ZN; Korsmeyer SJ
    Nature; 1994 May; 369(6478):321-3. PubMed ID: 8183370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel regulatory domain in Bcl-X(L) and Bcl-2.
    Chang BS; Minn AJ; Muchmore SW; Fesik SW; Thompson CB
    EMBO J; 1997 Mar; 16(5):968-77. PubMed ID: 9118958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A splicing variant of the Bcl-2 member Bok with a truncated BH3 domain induces apoptosis but does not dimerize with antiapoptotic Bcl-2 proteins in vitro.
    Hsu SY; Hsueh AJ
    J Biol Chem; 1998 Nov; 273(46):30139-46. PubMed ID: 9804769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The BH3 domain of Bax is sufficient for interaction of Bax with itself and with other family members and it is required for induction of apoptosis.
    Simonen M; Keller H; Heim J
    Eur J Biochem; 1997 Oct; 249(1):85-91. PubMed ID: 9363757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of BFL-1 for its interaction with BAX and its anti-apoptotic action in mammalian and yeast cells.
    Zhang H; Cowan-Jacob SW; Simonen M; Greenhalf W; Heim J; Meyhack B
    J Biol Chem; 2000 Apr; 275(15):11092-9. PubMed ID: 10753914
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function analysis of Bcl-2 family proteins. Regulators of programmed cell death.
    Reed JC; Zha H; Aime-Sempe C; Takayama S; Wang HG
    Adv Exp Med Biol; 1996; 406():99-112. PubMed ID: 8910675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bax- and Bak-induced cell death in the fission yeast Schizosaccharomyces pombe.
    Jürgensmeier JM; Krajewski S; Armstrong RC; Wilson GM; Oltersdorf T; Fritz LC; Reed JC; Ottilie S
    Mol Biol Cell; 1997 Feb; 8(2):325-39. PubMed ID: 9190211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bim(L) displacing Bcl-x(L) promotes Bax translocation during TNFalpha-induced apoptosis.
    Zhang L; Xing D; Chen M
    Apoptosis; 2008 Jul; 13(7):950-8. PubMed ID: 18500555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in prostate carcinoma cells by BH3 peptides which inhibit Bak/Bcl-2 interactions.
    Finnegan NM; Curtin JF; Prevost G; Morgan B; Cotter TG
    Br J Cancer; 2001 Jul; 85(1):115-21. PubMed ID: 11437412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural biology of the Bcl-2 family of proteins.
    Petros AM; Olejniczak ET; Fesik SW
    Biochim Biophys Acta; 2004 Mar; 1644(2-3):83-94. PubMed ID: 14996493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.